Radiopharmaceutical needed for prostate cancer patient with metastatic lesions after definitive treatment

Ended Awarded

Contract number
HT009022FG0510016
Awardee
Awarding agency
Obligated
$20,976

Award facts

Contract value 100% obligated
$20,976.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sterling, VA, USA

Award details come from SAM.gov/FPDS.

About this award

Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a firm fixed price contract valued at $20,976 by the Defense Health Agency to provide a radiopharmaceutical needed for a prostate cancer patient with metastatic lesions after definitive treatment. The contract has no set-aside designation and requires performance at Sterling, Virginia through September 30, 2022. As the healthcare component of the Department of Defense, this award supports the Defense Health Agency's mission to provide radiopharmaceuticals and related medical care to eligible beneficiaries with cancer and other illnesses.

Quick answers

Who was awarded contract HT009022FG0510016?

HT009022FG0510016 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on May 12, 2022.

How much is contract HT009022FG0510016 worth?

The government has obligated $20,976 on HT009022FG0510016.

Is contract HT009022FG0510016 an order under another contract?

Yes. HT009022FG0510016 is a BPA call under HT001421A0014, a blanket purchase agreement.

Was contract HT009022FG0510016 competed?

The extent of competition for HT009022FG0510016 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award